Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiation

Mesenchymal stem cells (MSCs) have been approved as a cellular drug for the treatment of a variety of immune-related diseases by the government of many countries'. Previous investigations, including ours, have shown that exosomes secreted by MSCs (MSC-ex) are one of the main factors responsible for ... View More